Huda A BinEssa Selected Research

PKF118-310

1/2021

β-Catenin Attenuation Inhibits Tumor Growth and Promotes Differentiation in a BRAFV600E-Driven Thyroid Cancer Animal Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huda A BinEssa Research Topics

Disease

3	Neoplasms (Cancer) 01/2021 - 01/2017
1	Congenital Hypothyroidism (Cretinism) 01/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2021
1	Multiple Hereditary Exostoses (Hereditary Multiple Exostoses) 01/2021
1	Thyroid Neoplasms (Thyroid Cancer) 01/2021
1	Autosomal Dominant Hypophosphatemic Rickets 01/2020
1	Type 1A Vitamin D Hydroxylation-Deficient Rickets 01/2020
1	Hypophosphatemic Rickets 01/2020
1	Hypophosphatemia 01/2018
1	Rickets (Rachitis) 07/2017
1	Papillary Thyroid Cancer 01/2017

Drug/Important Bio-Agent (IBA)

3	Phosphates (Orthophosphate)IBA 01/2020 - 07/2017
2	PLX 4720IBA 01/2021 - 01/2017
1	Thyroid HormonesIBA 01/2022
1	GlycosyltransferasesIBA 01/2021
1	PKF118-310IBA 01/2021
1	CateninsIBA 01/2021
1	25-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Vitamin D FDA LinkGeneric 01/2017
1	EnzymesIBA 01/2017
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2017
1	Vitamin D3 24-HydroxylaseIBA 01/2017